Skip to main content

Advertisement

SpringerLink
Log in

Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Precise diagnostic work up of a suspected thymic pathology in patients with myasthenia gravis (MG) is very important for potential surgical implications and further disease course. In this study the diagnostic value of combined preoperative radiological (CAT scan) and nuclear based imaging (octreotide and thallium scintigraphy) in patients with MG was evaluated. Twenty four patients were included. Histopathology revealed thymoma in nine patients, thymic carcinoma (TC) in one patient, lymphofollicular hyperplasia in seven patients, and involuted thymus in another seven patients. Diagnostic sensitivity for detecting thymoma/TC was 80 % in CAT scan as well as in somatostatin scintigraphy; the combination of both procedures reached 90 %. However, the diagnostic specifity to exclude thymoma in CAT scan was 100 % and in octreotide scintigraphy 85.7 %. Semiquantitative octreotide uptake significantly correlated with histological grading of thymoma/TC (r = 0.764) and histological proliferation rate Ki67 (r = 0.894). Thallium scintigraphy was positive only in one out of four thymoma cases. In this study, somatostatin scintigraphy has been shown to be a useful additional diagnostic technique in detecting thymic malignancies in patients with MG. These results might be especially helpful in patients with late onset MG as these patients are in general no candidates for thymectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100

    Article  CAS  PubMed  Google Scholar 

  2. Binks S, Vincent A, Palace J (2015) Myasthenia gravis: a clinical-immunological update. J Neurol [Epub ahead of print]

  3. Cea G, Benatar M, Verdugo RJ, Salinas RA (2013) Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 10:CD008111

    PubMed  Google Scholar 

  4. Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797–1810

    Article  CAS  PubMed  Google Scholar 

  5. Ferone D, van Hagen PM, Colao A, Annunziato L, Lamberts SW, Hofland LJ (1999) Somatostatin receptors in the thymus. Ann Med 31(Suppl 2):28–33

    CAS  PubMed  Google Scholar 

  6. Ferone D, van Hagen PM, van Koetsveld PM, Zuijderwijk J, Mooy DM, Lichtenauer-Kaligis EG, Colao A, Bogers AJ, Lombardi G, Lamberts SW, Hofland LJ (1999) In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology 140:373–380

    Article  CAS  PubMed  Google Scholar 

  7. Gao ZR, Kornblum C, Flacke S, Logvinski T, Yuksel M, An R, Klockgether T, Biersack HJ, Ezziddin S (2007) Somatostatin receptor scintigraphy in the follow-up of myasthenia gravis. Neurol Sci 28:175–180

    Article  CAS  PubMed  Google Scholar 

  8. Green AC, Marx A, Strobel P, Mason M, Lim E, Jordan S, Ladas G, Dusmet M, Rice A, Nicholson AG (2015) Type A and AB thymomas: histological features associated with increased stage. Histopathology 66:884–891

    Article  PubMed  Google Scholar 

  9. Guidoccio F, Grosso M, Maccauro M, Orsini F, Perri M, Boni G, Banti E, Grassetto G, Rubello D, Mariani G, Volterrani D (2011) Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses. Tumori 97:191–195

    PubMed  Google Scholar 

  10. Higuchi T, Taki J, Kinuya S, Yamada M, Kawasuji M, Matsui O, Nonomura A, Bunko H, Tonami N (2001) Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy. Radiology 221:201–206

    Article  CAS  PubMed  Google Scholar 

  11. Jordan B, Eger K, Zierz S (2009) Polymyositis associated with thymoma. Nervenarzt 80:708–711

    Article  CAS  PubMed  Google Scholar 

  12. Jordan B, Schilling S, Zierz S (2015) Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis. J Neurol [Epub ahead of print]

  13. Kelly RJ, Petrini I, Rajan A, Wang Y, Giaccone G (2011) Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol 29:4820–4827

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP (2010) Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer 17:R53–R73

    Article  CAS  PubMed  Google Scholar 

  15. Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caraco C, Bianco RA, Muto P, Salvatore M (1998) In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med 39:634–639

    CAS  PubMed  Google Scholar 

  16. Leonardo E, Volante M, Barbareschi M, Cavazza A, Dei Tos AP, Bussolati G, Papotti M (2007) Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact? Appl Immunohistochem Mol Morphol 15:220–223

    Article  CAS  PubMed  Google Scholar 

  17. Marienhagen J, Schalke B, Aebert H, Held P, Eilles C, Bogdahn U (1999) Somatostatin receptor scintigraphy in thymoma imaging method and clinical application. Pathol Res Pract 195:575–581

    Article  CAS  PubMed  Google Scholar 

  18. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG (2011) Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6:1274–1281

    Article  PubMed  Google Scholar 

  19. Marx A, Porubsky S, Belharazem D, Saruhan-Direskeneli G, Schalke B, Strobel P, Weis CA (2015) Thymoma related myasthenia gravis in humans and potential animal models. Exp Neurol 270:55–65

    Article  PubMed  Google Scholar 

  20. Marx A, Strobel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, Kurrer MO, Lauriola L, Marino M, Matsuno Y, Molina TJ, Mukai K, Nicholson AG, Nonaka D, Rieker R, Rosai J, Ruffini E, Travis WD (2014) ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol 9:596–611

    Article  CAS  PubMed  Google Scholar 

  21. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492

    Article  CAS  PubMed  Google Scholar 

  22. Nikolic A, Djukic P, Basta I, Hajdukovic L, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D (2013) The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Clin Neurol Neurosurg 115:432–437

    Article  CAS  PubMed  Google Scholar 

  23. Priola AM, Priola SM (2014) Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol 69:e230–e245

    Article  CAS  PubMed  Google Scholar 

  24. Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SW, Gebbers JO, Gersbach P, Laissue JA (1993) In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 82:2143–2151

    CAS  PubMed  Google Scholar 

  25. Ried M, Guth H, Potzger T, Diez C, Neu R, Schalke B, Hofmann HS (2011) Surgical resection of thymoma still represents the first choice of treatment. Thorac Cardiovasc Surg 60(2):145–149

    PubMed  Google Scholar 

  26. Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS (2013) Thymectomy: role in the treatment of myasthenia gravis. J Neurol 260:1798–1801

    Article  CAS  PubMed  Google Scholar 

  27. Uzawa A, Kawaguchi N, Kanai T, Himuro K, Oda F, Yoshida S, Yoshino I, Kuwabara S (2015) Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol 262:1019–1023

    Article  CAS  PubMed  Google Scholar 

  28. van Essen M, Sundin A, Krenning EP, Kwekkeboom DJ (2014) Neuroendocrine tumours: the role of imaging for diagnosis and therapy. Nat Rev Endocrinol 10:102–114

    Article  PubMed  Google Scholar 

  29. Vladislav IT, Gokmen-Polar Y, Kesler KA, Loehrer PJ Sr, Badve S (2013) The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases. Mod Pathol 26:1059–1064

    Article  PubMed  Google Scholar 

  30. Weksler B, Tavares J, Newhook TE, Greenleaf CE, Diehl JT (2012) Robot-assisted thymectomy is superior to transsternal thymectomy. Surg Endosc 26:261–266

    Article  PubMed  Google Scholar 

  31. Yasukawa Y, Yoshikawa H, Iwasa K, Yamada M, Takamori M (2004) Comparative study of pre-operative thymic imaging and pathology in patients with myasthenia gravis. J Clin Neurosci 11:610–613

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle/Saale, Germany

    Berit Jordan, Juliane Kellner & Stephan Zierz

  2. Department of Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle/Saale, Germany

    Karin Jordan

  3. Department of Nuclear Medicine, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle/Saale, Germany

    Manfred Bähre

  4. Department of Radiology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle/Saale, Germany

    Curd Behrmann

Authors
  1. Berit Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juliane Kellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karin Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manfred Bähre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Curd Behrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephan Zierz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berit Jordan.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jordan, B., Kellner, J., Jordan, K. et al. Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging. J Neurol 263, 641–648 (2016). https://doi.org/10.1007/s00415-016-8023-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-016-8023-5

Keywords

Search

Navigation